• Fri, July 30, 2021

by: WOPRAI

Robert Moskow Maintained (ACI) at Buy with Increased Target to $24 on, Jul 30th, 2021

by: WOPRAI

Nathan Race Maintained (ALRS) at Hold with Decreased Target to $31 on, Jul 30th, 2021

by: WOPRAI

Jamie Cook Maintained (ALSN) at Buy with Decreased Target to $51 on, Jul 30th, 2021

by: WOPRAI

Geoffrey Porges Maintained (VRTX) at Sell with Increased Target to $175 on, Jul 30th, 2021

by: WOPRAI

Brian Abrahams Maintained (VRTX) at Buy with Increased Target to $248 on, Jul 30th, 2021

by: WOPRAI

Edward Tenthoff Maintained (VRTX) at Buy with Increased Target to $323 on, Jul 30th, 2021

by: WOPRAI

Matthew Harrison Maintained (VRTX) at Hold with Decreased Target to $202 on, Jul 30th, 2021

by: WOPRAI

Justin Jenkins Maintained (VLO) at Strong Buy with Decreased Target to $88 on, Jul 30th, 2021

by: WOPRAI

TJ Schultz Maintained (VLO) at Buy with Increased Target to $92 on, Jul 30th, 2021

by: WOPRAI

Rajvindra Gill Maintained (SWKS) at Strong Buy with Increased Target to $255 on, Jul 30th, 2021

by: WOPRAI

Vijay Rakesh Maintained (SWKS) at Strong Buy with Increased Target to $215 on, Jul 30th, 2021

by: WOPRAI

Craig Ellis Maintained (SWKS) at Strong Buy with Increased Target to $245 on, Jul 30th, 2021

by: WOPRAI

Craig Hettenbach Maintained (SWKS) at Hold with Increased Target to $204 on, Jul 30th, 2021

by: WOPRAI

Joseph Altobello Maintained (BC) at Buy with Increased Target to $124 on, Jul 30th, 2021

by: WOPRAI

Joseph Spak Maintained (BC) at Hold with Increased Target to $115 on, Jul 30th, 2021

by: WOPRAI

David Lebovitz Maintained (BPMC) at Hold with Decreased Target to $96 on, Jul 30th, 2021

by: WOPRAI

Michael Cyprys Maintained (BSIG) at Buy with Increased Target to $30 on, Jul 30th, 2021

by: WOPRAI

Yi Chen Maintained (ZYXI) at Strong Buy with Decreased Target to $20 on, Jul 30th, 2021

by: WOPRAI

Mark Hughes Maintained (AFL) at Hold with Increased Target to $56 on, Jul 30th, 2021

by: WOPRAI

Jamie Cook Maintained (AGCO) at Buy with Increased Target to $163 on, Jul 30th, 2021

by: WOPRAI

Trevor Cranston Maintained (AGNC) at Buy with Decreased Target to $17 on, Jul 30th, 2021

by: WOPRAI

Salveen Richter Downgraded (AGIO) to Strong Sell and Decreased Target to $39 on, Jul 30th, 2021

by: WOPRAI

Michael King Maintained (AGIO) at Strong Buy with Increased Target to $93 on, Jul 30th, 2021

by: WOPRAI

Caitlin Dullanty Upgraded (AIN) to Strong Buy and Held Target at $105 on, Jul 30th, 2021

by: WOPRAI

Vijay Rakesh Maintained (ALGM) at Strong Buy with Increased Target to $40 on, Jul 30th, 2021

by: WOPRAI

Alexander Goldfarb Upgraded (ALEX) to Buy and Increased Target to $22 on, Jul 30th, 2021

by: WOPRAI

Elyse Greenspan Maintained (AJG) at Buy with Increased Target to $165 on, Jul 30th, 2021

by: WOPRAI

Mark Dwelle Maintained (AJG) at Hold with Increased Target to $150 on, Jul 30th, 2021

by: WOPRAI

Paul Knight Maintained (AVTR) at Buy with Increased Target to $45 on, Jul 30th, 2021

by: WOPRAI

Dan Leonard Maintained (AVTR) at Buy with Increased Target to $44 on, Jul 30th, 2021

by: WOPRAI

Erin Wright Maintained (AVTR) at Buy with Increased Target to $42 on, Jul 30th, 2021

by: WOPRAI

Jeffrey Zekauskas Upgraded (ASH) to Hold and Held Target at $90 on, Jul 30th, 2021

by: WOPRAI

Jed Dorsheimer Maintained (ASPN) at Strong Buy with Increased Target to $45 on, Jul 30th, 2021

by: WOPRAI

Brad Heffern Maintained (AVB) at Hold with Increased Target to $229 on, Jul 30th, 2021

by: WOPRAI

Richard Newitter Maintained (TFX) at Hold with Increased Target to $415 on, Jul 30th, 2021

by: WOPRAI

Christopher Glynn Maintained (TEL) at Buy with Increased Target to $155 on, Jul 30th, 2021

by: WOPRAI

Gregg Moskowitz Maintained (TEAM) at Strong Buy with Increased Target to $370 on, Jul 30th, 2021

by: WOPRAI

Michael Turrin Maintained (TEAM) at Buy with Increased Target to $325 on, Jul 30th, 2021

by: WOPRAI

David Hynes Maintained (TEAM) at Strong Buy with Increased Target to $325 on, Jul 30th, 2021

by: WOPRAI

Joel Fishbein Maintained (TEAM) at Hold with Increased Target to $270 on, Jul 30th, 2021

by: WOPRAI

James Fish Maintained (TEAM) at Buy with Increased Target to $308 on, Jul 30th, 2021

by: WOPRAI

Keith Weiss Maintained (TEAM) at Buy with Increased Target to $320 on, Jul 30th, 2021

by: WOPRAI

Joseph Giordano Maintained (TDY) at Buy with Increased Target to $525 on, Jul 30th, 2021

by: WOPRAI

Kenneth Lee Maintained (ARCC) at Buy with Increased Target to $22 on, Jul 30th, 2021

by: WOPRAI

James Lee Maintained (AMZN) at Strong Buy with Decreased Target to $205 on, Jul 30th, 2021

by: WOPRAI

Aaron Kessler Maintained (AMZN) at Buy with Decreased Target to $195 on, Jul 30th, 2021

by: WOPRAI

Stephen Ju Maintained (AMZN) at Buy with Decreased Target to $235 on, Jul 30th, 2021

by: WOPRAI

John Blackledge Maintained (AMZN) at Buy with Decreased Target to $220 on, Jul 30th, 2021

Salveen Richter Downgraded (AGIO) to Strong Sell and Decreased Target to $39 on, Jul 30th, 2021

Salveen Richter of Goldman Sachs, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Strong Sell and Decreased Target from $58 to $39 on, Jul 30th, 2021.

Salveen has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


This is the rating of the analyst that currently disagrees with Salveen

  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Friday, April 30th, 2021

Like: 👍